Frankfurt - Delayed Quote EUR

Bio-Gate AG (BIG1.F)

0.6500
0.0000
(0.00%)
As of 9:15:01 AM GMT+2. Market Open.
Loading Chart for BIG1.F
  • Previous Close 0.6500
  • Open 0.6050
  • Bid 0.6500 x --
  • Ask 0.7200 x --
  • Day's Range 0.6050 - 0.6500
  • 52 Week Range 0.5250 - 1.1500
  • Volume 2,000
  • Avg. Volume 292
  • Market Cap (intraday) 6.008M
  • Beta (5Y Monthly) 0.22
  • PE Ratio (TTM) --
  • EPS (TTM) -0.2200
  • Earnings Date May 14, 2025 - May 20, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Bio-Gate AG provides technologies and customized solutions for health and hygiene in Germany. The company offers HyProtect, a plasma coating, which protects the surfaces of medical implants against bacterial colonization. It also provides MicroSilver BG elemental microporous silver additives. The company's products are used in large and medium-sized medical technology companies, pharmaceutical distributors, distribution companies, industrial companies, public sector companies, and hygiene-sensitive institutions. The company was incorporated in 2005 and is based in Nuremberg, Germany.

www.bio-gate.de

45

Full Time Employees

December 31

Fiscal Year Ends

Recent News: BIG1.F

View More

Performance Overview: BIG1.F

Trailing total returns as of 5/14/2025, which may include dividends or other distributions. Benchmark is DAX P (^GDAXI) .

YTD Return

BIG1.F
12.16%
DAX P (^GDAXI)
18.35%

1-Year Return

BIG1.F
36.89%
DAX P (^GDAXI)
25.89%

3-Year Return

BIG1.F
77.59%
DAX P (^GDAXI)
67.96%

5-Year Return

BIG1.F
56.95%
DAX P (^GDAXI)
127.93%

Compare To: BIG1.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BIG1.F

View More

Valuation Measures

As of 5/13/2025
  • Market Cap

    5.78M

  • Enterprise Value

    5.30M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.80

  • Price/Book (mrq)

    2.62

  • Enterprise Value/Revenue

    0.70

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -26.32%

  • Return on Assets (ttm)

    -25.82%

  • Return on Equity (ttm)

    -68.91%

  • Revenue (ttm)

    7.61M

  • Net Income Avi to Common (ttm)

    -2M

  • Diluted EPS (ttm)

    -0.2200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    476k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -169.26k

Research Analysis: BIG1.F

View More